Report updated Apr 23, 2026
Level One: A Diabetes Game
For individuals with Type 1 Diabetes, their families, and professional caregivers such as school nurses and camp counselors.
Overview · Full Intel report in progress
Level One: A Diabetes Game is an established medical app that is completely free. With a 4.7/5 rating from 405 reviews, it shows polarized user reception.
What makes this app unique?
What Does It Look Like?
What Are The Key Features?
Interactive levels teach users how to calculate bolus, dose insulin, and manage carb ratios.
Provides guidance on the operation and usage of continuous glucose monitors (CGMs) including Dexcom, Libre, and Medtronic.
Covers complex scenarios such as managing ketones, exercise, and blood sugar fluctuations.
How much does it cost?
Who Built It?
Relevate Health Group
Developing specialized medical education games to improve clinical decision-making and patient management. Bridging the gap between complex medical research and practical application through gamified training.
Portfolio
3
Apps
What other apps does Relevate Health Group make?
Explore the full Relevate Health Group report
Portfolio breakdown, audience, momentum, and every app published by Relevate Health Group.
Analysis in progress, available soon
What do users think recently?
Analysis in progress, available soon
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
Analysis in progress, available soon
What is the competitive landscape for Level One: A Diabetes Game?
Where is it available?
Localized markets (1)
How's The Medical Market?
How does it evolve in the Medical market?
Rank progression
2 active rankings tracked — 30-day window
Strategic analysis coming soon
SWOT, key takeaways & outlook
The outtake for Level One: A Diabetes Game
Key Takeaways
Level One is a free, gamified educational tool designed to help users master the clinical complexities of Type 1 Diabetes management.
Where Is It Heading?
Trend analysis
Available very soon